Alexander KarpAlexander Karp earned $1B in 2024

In 2023, Charles R. Kummeth earned $6.21M in total compensation at Bio-Techne, including $1.18M salary and $5.00M in stock. Most recently acquired 170,000 shares in Aug 2024. Currently holds stock worth $511.20K. Led Bio-Techne as CEO for 10 years.

Compensation History

Annual executive compensation data for Charles R. Kummeth, including salary, bonuses, and stock awards.

Year

2023

Total Compensation

$6.21M

Salary

$1.18M

Bonus

$0.00

Other

$21.14K

Salary

$1.18M

Board Justification

The compensation philosophy emphasizes alignment with company performance, retention strategies, and competitive benchmarking against peers.

Bonus

$0.00

Board Justification

No cash bonus was awarded for fiscal year 2023 due to performance metrics not being met.

Other Compensation

$21.14K

Board Justification

Other compensation includes 401(k) match and dividends paid on unvested restricted stock.

Restricted Stock

$5.00M5M RSU

Board Justification

The stock awards that vested in 2023 were time-based restricted stock units granted in prior years, with a total value of $5,000,028 at grant date assuming maximum performance conditions.

Performance Metrics

The performance metrics for the CEO's compensation included organic revenue growth and adjusted operating income.

B

Charles R. Kummeth

Ex-CEO of Bio-Techne

Sector of Economy

Healthcare

CEO of Bio-Techne for

10 years 10 months (Apr 2013 - Feb 2024)

Previous Experience

Unknown

Holdings

Track Charles R. Kummeth's stock holdings and portfolio value over time.

Insider Trading

Charles R. Kummeth's recent stock transactions, purchases, and sales filed with the SEC.

QSI

$149.25K

QSI at $0.88/share

Aug 9, 2024

Purchase

Rivals

Compare Charles R. Kummeth with competitor CEOs and industry peers.